Article ; Online: Comprehensive analysis of lncRNA-TF crosstalks and identification of prognostic regulatory feedback loops of glioblastoma using lncRNA/TF-mediated ceRNA network.
Journal of cellular biochemistry
2019 Volume 121, Issue 1, Page(s) 755–767
Abstract: Glioblastoma (GBM) has become the most aggressive primary brain tumor in the world. Patients with GBM usually have a poor prognosis. The median survival times of GBM patients retain less than 2 years. Thus, it is urgent to investigate the molecular ... ...
| Abstract | Glioblastoma (GBM) has become the most aggressive primary brain tumor in the world. Patients with GBM usually have a poor prognosis. The median survival times of GBM patients retain less than 2 years. Thus, it is urgent to investigate the molecular mechanism of GBM. Recently, studies have demonstrated that transcription factors (TFs) participate in cancer pathology by regulating long noncoding RNAs (lncRNAs). However, the functional and regulatory roles of TF-lncRNA crosstalks are still unclear. In this study, we constructed a global lncRNA-TF network (GLTN) based on competing endogenous RNA. As a result, some topological features of GLTN were identified. A known GBM lncRNA MCM3AP-AS1 showed multiple central topological features in GLTN. Furthermore, we identified hub genes and extracted the hub-hub pairs from GLTN to form a hub associated lncRNA-TF network (HALTN). Results showed that a risk model combined with multiple hubs had a significant effect on prognosis. Additionally, we performed module searching and two functional modules from HALTN were identified, which were confirmed as risk factors of GBM. More importantly, we also identified some core lncRNA-TF crosstalks that might form feedback loops to control the biological processes in GBM. Our results demonstrated that the synergistic, competitive lncRNA-TF crosstalks played an important role in pathological processes of GBM, and had strong effect on prognosis. All these results can help us to uncover the molecular mechanism and provide a new therapeutic target for GBM. |
|---|---|
| MeSH term(s) | Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Feedback, Physiological ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Gene Regulatory Networks ; Glioblastoma/genetics ; Glioblastoma/metabolism ; Glioblastoma/pathology ; Humans ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Prognosis ; RNA, Long Noncoding/genetics ; RNA, Long Noncoding/metabolism ; Survival Rate ; Transcription Factors/genetics ; Transcription Factors/metabolism |
| Chemical Substances | Biomarkers, Tumor ; MicroRNAs ; RNA, Long Noncoding ; Transcription Factors |
| Language | English |
| Publishing date | 2019-09-03 |
| Publishing country | United States |
| Document type | Journal Article |
| ZDB-ID | 392402-6 |
| ISSN | 1097-4644 ; 0730-2312 |
| ISSN (online) | 1097-4644 |
| ISSN | 0730-2312 |
| DOI | 10.1002/jcb.29321 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 1114: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.